Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: SBRT in HCC With Oligoprogression on First-line Immunotherapy [NA]
A clinical trial evaluating stereotactic body radiotherapy for hepatocellular carcinoma patients with oligoprogression on first-line immunot…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC) [NA]
An ongoing trial evaluating Eye90 Microspheres for hepatocellular carcinoma is currently active but not recruiting, including non-resectable…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention
A clinical trial is recruiting to develop and test a patient-facing educational tool for liver cancer prevention.
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Cabozantinib in Hepatocellular Carcinoma [Phase 2]
This entry notes a Phase 2 clinical trial of cabozantinib in hepatocellular carcinoma (NCT04588051) and states that the study is currently a…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Real-World Treatment Patterns and Survival Outcomes in Patients With Intermediate-Stage Hepatocellular Carcinoma.
A clinical trial update examining real-world treatment patterns and survival outcomes in patients with intermediate-stage hepatocellular car…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: A Study of AK112 in Patients With Advanced Hepatocellular Carcinoma (HCC) [Phase 1, Phase 2]
AK112 is being studied in a Phase 1/Phase 2 trial for advanced hepatocellular carcinoma and is currently recruiting. The study is sponsored …
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Pembrolizumab in Hepatocellular Carcinoma [Phase 2]
Pembrolizumab is being studied in a Phase 2 trial for hepatocellular carcinoma, and the study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Impact of Radiotherapy on ctDNA in Patients With Hepatocellular Carcinoma
A ClinicalTrials.gov study led by the Chinese University of Hong Kong is investigating how radiotherapy affects circulating tumor DNA in pat…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: SBRT With Immunotherapy and Atezo-Bev in HCC With Major Portal Vein Thrombosis [Phase 2]
Phase 2 trial evaluating stereotactic body radiotherapy (SBRT) with immunotherapy and atezolizumab-bevacizumab in hepatocellular carcinoma w…
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies [Phase 1, Phase 2]
A Phase 1/2 trial evaluating the combination of anti-CTLA4-NF mAb (BMS-986218), nivolumab, and stereotactic body radiation therapy for metas…
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Evaluation of Stereotactic Body Radiotherapy as a Bridge Therapy for Hepatocellular Carcinoma Patients Enlisted for Liver Transplantation [Phase 2]
Phase 2 trial evaluating stereotactic body radiotherapy as a bridge therapy for patients with hepatocellular carcinoma listed for liver tran…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: THIO and Cadonilimab in Resectable Hepatocellular Carcinoma [EARLY_Phase 1]
An early-phase trial evaluating THIO in combination with Cadonilimab for resectable hepatocellular carcinoma. The study is not yet recruitin…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Safety and Efficacy of Transarterial ICG Fluorescence-Guided Laparoscopic Anatomical Liver Resection
An update on a clinical trial evaluating safety and efficacy of transarterial Indocyanine Green fluorescence-guided laparoscopic liver resec…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: IDOV-Immune for Advanced Solid Tumors [Phase 1]
This report summarizes a Phase 1 trial of IDOV-Immune from ViroMissile, Inc. for advanced solid tumors, which is currently recruiting across…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Transarterial Chemoembolization (TACE) Plus ABCB1 Inhibition Versus TACE Alone in Patients With Hepatocellular Carcinoma [Phase 2, Phase 3]
Ongoing Phase 2/3 clinical study evaluating transarterial chemoembolization (TACE) with ABCB1 inhibition versus TACE alone for hepatocellula…
-
EMA approval · 2026-02-27EMA Authorised: Cabometyx (cabozantinib (s)-malate) — Ipsen Pharma
The EMA authorised Cabometyx (cabozantinib (s)-malate) for renal cell carcinoma and hepatocellular carcinoma in the EU, with Ipsen Pharma as…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Ligufalimab and Cadonilimab in Advanced Liver Cancers [Phase 2]
Phase 2 clinical trial update on Ligufalimab and Cadonilimab in advanced hepatocellular carcinoma and biliary tract cancer, currently recrui…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Exploring the Application of 3D Bioprinting for Personalized Treatment in Primary Liver Cancer With Tumor Microenvironment
A clinical trial update describing a study using 3D bioprinting to develop personalized treatments for hepatocellular carcinoma, with emphas…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Impact of Emotional Status on Prognosis of Patients With BCLC Stage B/C Hepatocellular Carcinoma Undergoing Hepatic Arterial Infusion Chemotherapy Combined With Targeted and Immunotherapy
ClinicalTrials.gov lists a recruiting study evaluating whether emotional distress affects prognosis in patients with BCLC stage B/C hepatoce…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Decoding Epigenetic Mechanisms Driving Immune Evasion in Liver Cancer With Omics Approaches
A clinical trial investigating epigenetic mechanisms driving immune evasion in hepatocellular carcinoma using omics approaches. The study is…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis
This clinical trial update describes an Active Choice Clinical Decision Support study aimed at improving screening for hepatocellular carcin…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: Hepatic Artery Infusion Chemotherapy (HAIC) Plus Durvalumab for Advanced Hepatocellular Carcinoma [Phase 2]
This Phase 2 trial evaluating hepatic artery infusion chemotherapy in combination with durvalumab for advanced hepatocellular carcinoma has …
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: A Phase 2, Open-Label Study of ABSK-011 Combined Atezolizumab or SOC in HCC Patients [Phase 2]
A Phase 2, open-label trial evaluating ABSK-011 in combination with atezolizumab or standard of care in patients with hepatocellular carcino…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Liver Cancer Prevention Randomized Control Trial [NA]
This clinical trial update reports an active-not-recruiting randomized controlled trial aimed at preventing liver cancer. The study lists MD…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 trial evaluating Q702, an oral Axl/Mer/CSF1R tyrosine kinase inhibitor, in combination with pembrolizumab, for selected advanced…